USSTOCK.TODAY
Market Closed
Log in Sign up

Nektar Therapeutics to Announce Q3 Results and Key Updates

Nasdaq +1 · ·by G4L

NKTR
NKTR Nektar Therapeutics
$37.27 +0.05%
View chart & analysis →
  1. 1Nektar Therapeutics will announce its third-quarter results after the market closes on November 12.
  2. 2The consensus estimate for Nektar Therapeutics' third-quarter net loss per share is $2.16.
  3. 3Nektar Therapeutics will conduct two EADV oral presentations in October.

So what's the key point?

Nektar Therapeutics is set to release its third-quarter results on November 12. Experts expect a net loss of approximately $2.16 per share.

Source Nasdaq +1 · View original ↗

Related 3-line summaries

Nektar Therapeutics reports $1.63 loss per share in Q3 Earnings Whispers · 10m agoPotential Rebound for NeoCloud Stocks The Motley Fool +1 · Nov 5Intrepid Potash Announces Q3 Results: Trio Production Increase and Share Buybacks The Motley Fool +1 · Nov 5
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news